Molecule Details
| InChIKey | VHTVGRLZQWFMBU-UHFFFAOYSA-N |
|---|---|
| Compound Name | 3-[4-[5-Chloro-2-[(3-methyl-1,2-thiazol-5-yl)amino]pyrimidin-4-yl]pyrazol-1-yl]propanenitrile |
| Canonical SMILES | Cc1cc(Nc2ncc(Cl)c(-c3cnn(CCC#N)c3)n2)sn1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.16 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P29597 | TYK2 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 8.8 | IC50 | ChEMBL |
| O60674 | JAK2 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 8.7 | IC50 | ChEMBL |
| P23458 | JAK1 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 8.5 | IC50 | ChEMBL |
| P52333 | JAK3 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 8.2 | IC50 | ChEMBL |
| P40763 | STAT3 | Homo sapiens | Human | PF00017 PF01017 PF02864 PF02865 PF21354 | 6.6 | IC50 | ChEMBL |